Atreca Appoints Clinical Development Leader Lori Kunkel, M.D., As A Technical Advisor

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today the appointment of Lori Kunkel, M.D., as a technical Advisor. Dr. Kunkel has an esteemed track record in development of clinical and regulatory strategies resulting in the global commercialization of successful oncology products.

Back to news